462
Views
23
CrossRef citations to date
0
Altmetric
Articles

Preparation and characterization of PEPPSI-palladium N-heterocyclic carbene complexes using benzimidazolium salts catalyzed Suzuki–Miyaura cross coupling reaction and their antitumor and antimicrobial activities

, , , , &
Pages 516-527 | Received 20 Nov 2018, Accepted 05 Jan 2019, Published online: 21 Feb 2019
 

Abstract

New palladium complexes were efficiently synthesized from the reaction of benzimidazolium salts 2a–e, potassium carbonate (K2CO3) and palladium chloride (PdCl2) in pyridine (for 3a–e). The catalytic activity of these complexes in a catalytic system including palladium complexes and K2CO3 in DMF-H2O was evaluated in Suzuki–Miyaura cross-coupling reactions of aryl bromides and chlorides with phenylboronic acid. Our novel complexes show excellent catalytic activities with high turnover numbers (TON) and high turnover frequencies (TOF) (e.g. for the Suzuki–Miyaura reaction: TON up to 370 and TOF up to 123.3 h−1). Both benzimidazolium salts 2a–e and complexes 3 have been characterized using spectroscopic data and elemental analysis. The antimicrobial activity of the N-heterocyclic carbene palladium complexes 3a–e varies with the nature of the ligands. Also, the IC50 values of both, complexes (3a–e) and benzimidazoles 2a–e, have been determined. In addition, the new palladium complexes were screened for their antitumor activity. Complexes 3e and 3d exhibited the highest antitumor effect with IC50 values 6.85 μg/mL against MCF-7 and 10.75 μg/mL against T47D, respectively.

Acknowledgements

The authors gratefully acknowledge Qassim University, represented by the Deanship of Scientific Research, on the material support for this research under the number 2348-alrasscac-2018-1-14-S during the academic year 1440/2019AD.

Disclosure statement

No potential conflict of interest was reported by the authors.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.